PubMed:1502171 / 159-326
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 16-71 | DNA | denotes | major histocompatibility complex class II gene promoter |
| T5 | 72-75 | DNA | denotes | DRA |
| T6 | 116-134 | DNA | denotes | cis-acting regions |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C4 | 12-75 | NP | denotes | the major histocompatibility complex class II gene promoter DRA |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S2 | 0-167 | Sentence | denotes | Analysis of the major histocompatibility complex class II gene promoter DRA has previously identified at least five cis-acting regions required for maximal expression. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 16-57 | protein_complex | denotes | major histocompatibility complex class II |
| T7 | 72-75 | DNA_domain_or_region | denotes | DRA |
| T8 | 116-134 | DNA_domain_or_region | denotes | cis-acting regions |